07/05/2026
Last week our second year medicinal chemists took part in a drug design exercise, starting with a lead analogue and going through iterative rounds of modification to hopefully produce a drug with nanomolar activity! They probed the structure-activity relationship, sought out improved binding, and looked to improve properties like logP. They all engaged wonderfully in the process, which is designed to mimic real drug discovery teamwork, and we look forward to reading the work that they submit! 💊🥼